new semaglutide injection Novo Nordisk medicines containing such as those who are obese or have weight Novo Nordisk's Wegovy® HD available

It's a decision made with your provider based on how your treatment is going

The information contained in the monograph is not a substitute for medical care

Consistent reduction in major cardiovascular events, even beyond glycaemic effects Meaningful kidney protection, slower eGFR decline & reduced albuminuria Benefits across phenotypes: diabetes, obesity, HFpEF, CKD & ASCVD A clear shift from organ-specific treatment to system-level risk reduction The next phase feels less about whether these agents work & more about who benefits most, when to start & how to integrate them alongside SGLT2 inhibitors and standard CV therapies

Rhonda Patrick has also used weekly intravenous Vitamin C infusions in the past